Latest AI and machine learning research in allergy & immunology for healthcare professionals.
Cancer has increasingly been recognized as a genetic disease, influenced by lifestyle changes, dieta...
Sepsis is a systemic inflammatory response syndrome that predisposes to severe lung infections (SeAL...
Bladder cancer is the fourth most common malignant tumor in men, with limited therapeutic biomarkers...
BACKGROUND AND PURPOSE: The efficacy of immunotherapy in non-small cell lung cancer (NSCLC) is intri...
This paper explores how artificial intelligence (AI) is being woven into precision medicine for neur...
INTRODUCTION: A significant challenge in treating non-small cell lung cancer (NSCLC) is its inherent...
HIV-1 protease inhibitors are crucial for antiviral therapies targeting acquired immunodeficiency sy...
BACKGROUND: Atopic dermatitis (AD) is a prevalent chronic and recurrent skin condition in children. ...
The tumor microenvironment (TME) significantly influences cancer prognosis and therapeutic outcomes,...
Accurate predictions of T cell receptor (TCR) specificity remain an important open problem in immuno...
Spinal cord injury (SCI) causes multifaceted postural and motor impairments that are challenging to ...
The increasing incidence of antimicrobial resistance is becoming a serious concern worldwide and req...
Immunogenic cell death (ICD) has been implicated in sepsis, a condition with high mortality, through...
In recent years,immunotherapy,particularly immune checkpoint inhibitors,has been widely used in the ...
Checkpoint inhibitors (ICIs) are key therapies for NSCLC, but current selection criteria, such as e...
Rickettsia is a genus of bacteria that are obligate intracellular parasites and are responsible for ...
Engineered T-cell receptor (eTCR) systems rely on accurately generated T-cell receptor (TCR) sequenc...
Breast cancer is the leading cause of cancer-related mortality among women worldwide. The developmen...
Glioblastoma multiforme, one of the most malignant types of brain tumor, heavily relies on glycolyti...
Non-small cell lung cancer (NSCLC) constitutes over 80% of lung cancer cases and remains a leading c...
Despite the STING-type-I interferon pathway playing a key role in effective anti-tumor immunity, the...